Triangle Business Journal -- GlaxoSmithKline, which is pushing to extend its reach in Latin America, has taken a step in that direction with an agreement to buy Argentina-based Laboratorios Phoenix for $253 million in cash.
Triangle Business Journal -- GlaxoSmithKline, which is pushing to extend its reach in Latin America, has taken a step in that direction with an agreement to buy Argentina-based Laboratorios Phoenix for $253 million in cash.
